Dr. Prakash Pandit has extensive, hands-on experience with the latest radiotherapy equipment and independent planning and implementation of IMRT, IGRT, 3DCRT plans.
His areas of interest include head and neck tumours, breast cancer, APBI, brachytherapy for gynaecological tumours, and brachytherapy.
Dr. Pandit has so far treated over 15000 cases.
Dr. Pandit is the recipient of multiple awards.
He is a member of the Association of Radiation Oncologists of India (AROI).
Prevalence of molecular subtypes of breast cancer: a single institutional experience of 2062 patients (2020). European journal of breast health, 16(1), 39.
Predictors of weight loss in patients with head and neck cancer receiving radiation or concurrent chemoradiation treated at a tertiary cancer center (2020). Nutrition in Clinical Practice, 35(6), 1047-1052.
A Case Of Fibrolamellar Hepatocellular Carcinoma Managed Surgically At Atertiary Care Cancer Centre (2017). Journal of Cancer Research & Therapeutics, 13.
Evaluation of Prognostic Factors that Affect Survival Outcomes of Breast Cancer Patients with Brain Metastases: A Single Institutional Experience (2021). European Journal of Breast Health, 17(1), 62.
Factors influencing non-adherence to radiotherapy: a retrospective audit of 1,548 patients from a tertiary cancer centre (2020). Journal of Radiotherapy in Practice, 19(4), 359-364.
Impact of adjuvant systemic chemotherapy on wound healing and cosmetic outcome in 224 women treated with accelerated partial breast irradiation using interstitial brachytherapy (2017). Brachytherapy, 16(5), 935-942.
HCG - The Specialist in Cancer Care, India’s largest provider of cancer care, is at the forefront of the battle against cancer. Through its network of 21 comprehensive cancer centers, spread across India, HCG has brought advanced cancer care to the doorstep of millions of people.